Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-2,377
Closed -$217K 839
2023
Q2
$217K Buy
+2,377
New +$195K 0.02% 696
2022
Q4
Sell
-2,498
Closed -$241 740
2022
Q3
$241 Sell
2,498
-92
-4% -$11K 0.01% 601
2022
Q2
$272K Buy
2,590
+349
+16% +$44.6K 0.04% 488
2022
Q1
$386K Sell
2,241
-205
-8% -$30.6K 0.04% 439
2021
Q4
$396K Sell
2,446
-323
-12% -$51.9K 0.04% 423
2021
Q3
$469K Buy
2,769
+925
+50% +$192K 0.06% 357
2021
Q2
$452K Sell
1,844
-4
-0.2% -$1.05K 0.06% 362
2021
Q1
$489K Buy
1,848
+586
+46% +$165K 0.08% 301
2020
Q4
$370K Sell
1,262
-256
-17% -$65.6K 0.08% 326
2020
Q3
$359K Sell
1,518
-126
-8% -$28.6K 0.09% 307
2020
Q2
$326K Sell
1,644
-38
-2% -$7.09K 0.08% 312
2020
Q1
$308K Sell
1,682
-629
-27% -$112K 0.1% 269
2019
Q4
$385K Buy
2,311
+710
+44% +$106K 0.1% 278
2019
Q3
$210K Buy
+1,601
New +$208K 0.06% 392

Other funds holding AMED

MGO One Seven's AMED Position: Q3 2023 in Review

MGO One Seven sold out of Amedisys (AMED) in Q3 2023, closing a stake of 2,377 shares — an estimated $217K sold.

MGO One Seven first reported a position in AMED in Q3 2019 and held it in 14 quarters. The position peaked at $489K in Q1 2021. 286 funds tracked by Wall St. Rank hold AMED as of Q3 2023.

  • MGO One Seven reported no remaining Amedisys position as of Q3 2023 after selling out during the quarter.
  • MGO One Seven sold 2,377 Amedisys shares in Q3 2023, an estimated $217K.
  • MGO One Seven first reported a position in Amedisys in Q3 2019 and held it in 14 quarters.
  • MGO One Seven's Amedisys position peaked at $489K in Q1 2021.
  • 286 funds tracked by Wall St. Rank held Amedisys as of Q3 2023.

Based on MGO One Seven's 13F filing for Q3 2023, filed 3 Nov 2023.